Clinical research reliable commercial drug sourcing UK and Europe: Global clinical trial supply services tailored for you! Strategic Sourcing – ClientPharma’s ethos is to challenge the norms and adapt to your specific needs. We understand the difficulties of multi-faceted projects with time and temperature delivery requirements. Biosimilars & Reference Medicines – ClientPharma’s clinical trial Project Management team brings proficiency in management and mitigation of risks. You can say goodbye to issues and delays and hello to peace-of-mind. Find even more details on warehousing and distribution for drugs.
ClientPharma is licensed and follows regulatory directives and guidelines, complying with Good Distribution Practice (GDP) for Medicines for Human Use, 2013/C 343/01. Our Quality Department is responsible for vigorously maintaining the quality and integrity of your products through our comprehensive Quality Management System. Continuous focus and commitment to quality assures compliance across the board — for the client, for the regulatory agencies, and most importantly, for the patient.
Our open and collaborative approach is tailored to you and your patients’ needs for every study. With dedicated points-of-contact and direct access to senior management, you are always in connection with us. Through regular business review meetings and custom KPIs, we never lose sight of what’s important to you, your team and your program. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch.
ClientPharma is proud to be the new sponsor of the Stretton Starlings netball team, continuing our goal to support equality in sports. As a result, we wish to showcase the team’s smart new match uniforms for the upcoming season, which sets a new precedent as an innovative way forward with the team wearing t-shirts rather than the ‘status quo’ netball dresses. After forming the team six months ago, the Starlings have just completed their first season collectively in a competitive netball league for the first time, emphasizing that age is no barrier with a range from 14 to 47 years old. The team has high expectations for the upcoming season and wishes to inspire, grow, develop, and celebrate local talent in welcoming ladies of all ages and abilities to come and join the team! Stretton Starlings are eager, driven and determined to commence the second season of the Leagues4you Burton-Upon-Trent Netball League, starting from the 9th of January 2023. Read additional information on https://www.clientpharma.com/.
Under this partnership, clients will now enjoy an expanded reach by leveraging ClientPharma’s global sourcing, procurement and distribution logistics while also having the ability to utilize the RxStudy CardTM, TrialCard’s virtual inventory supply solution that has been augmented to place physical inventories of medication at sites for protocol designs that require immediate dosing. This will cut supply costs by 50% and reduce clinical supply teams’ efforts by 80%. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.
